Filter
2957
Filtered Results: 2957
Text search:
epidemiological
studies
Featured
Recommendations
257
New Publications
694
Language
Document type
No document type
1658
Studies & Reports
621
Guidelines
371
Manuals
120
Strategic & Response Plan
96
Fact sheets
44
Training Material
22
Situation Updates
17
Resource Platforms
5
Infographics
2
Brochures
1
Countries / Regions
India
141
Global
129
Western and Central Europe
86
Latin America and the Carribbean
79
Sierra Leone
62
Africa
57
Ethiopia
55
Kenya
54
Liberia
52
South Africa
50
Uganda
45
Nigeria
44
Rwanda
39
Brazil
38
Nepal
34
Eastern Europe
34
Malawi
30
Venezuela
30
Zambia
28
Ghana
27
Tanzania
24
Bangladesh
24
Ukraine
24
Myanmar / Burma
23
West and Central Africa
23
Asia
23
Russia
23
Mozambique
22
Guinea
21
Germany
20
Philippines
19
Colombia
19
East and Southern Africa
19
South–East Asia Region
19
Namibia
17
Congo, Democratic Republic of
15
Paraguay
15
Cambodia
13
Indonesia
13
Argentina
13
Peru
13
Senegal
12
Zimbabwe
12
Lesotho
12
Middle East and North Africa
12
Eastern Europe and Central Asia
12
Syria
11
Tajikistan
11
Pakistan
10
Botswana
10
Bolivia
9
Chile
9
Albania
9
Burkina Faso
8
Ecuador
8
Eswatini/ Swaziland
7
Cameroon
6
Haiti
6
Benin
6
Western Pacific Region
6
USA
5
Sudan
5
Yemen
5
Southern Africa
5
Georgia
5
North America
5
Iraq
4
Jordan
4
Afghanistan
4
Lebanon
4
China
4
El Salvador
4
Angola
4
Madagascar
4
Armenia
4
Kyrgyzstan
4
Mali
3
North Macedonia
3
Sri Lanka
3
Moldova
3
Vietnam
3
Côte d’Ivoire / Ivory Coast
2
Saudi Arabia
2
Niger
2
Somalia
2
South Sudan
2
Turkey
2
Egypt
2
Chad
2
Thailand
2
Gambia
2
Central African Republic
2
Serbia
2
Burundi
2
Libya
2
Guatemala
2
Mexico
2
Bhutan
2
Laos
2
Iran
2
Uzbekistan
2
Kazakhstan
2
Jamaica
2
Mauritius
2
United Kingdom
2
Spain
2
Bosnia and Herzegovina
2
Guinea-Bissau
1
Morocco
1
Ireland
1
Singapore
1
Dominican Republic
1
Cuba
1
Honduras
1
Greece
1
Nicaragua
1
Poland
1
Palestine
1
North Korea
1
Italy
1
Djibouti
1
Timor Leste/ East Timor
1
Qatar
1
Estonia
1
Lithuania
1
Uruguay
1
Turkmenistan
1
France
1
Maldives
1
Tunisia
1
Portugal
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
995
Clinical Guidelines
269
Public Health
213
Women & Child Health
83
Key Resources
69
Pharmacy & Technologies
34
Capacity Building
25
Toolboxes
COVID-19
304
HIV
278
Mental Health
277
TB
265
Rapid Response
143
NTDs
132
Planetary Health
121
NCDs
89
Ebola
86
AMR
82
Disability
46
Zika
43
Global Health Education
41
Caregiver
33
Pharmacy
30
Refugee
26
Cholera
23
Polio
22
Conflict
21
Health Financing Toolbox
20
Natural Hazards
17
Specific Hazards
11
Social Ethics
5
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID...
The availability of water, sanitation and hygiene (WASH) services in health care facilities, especially in maternity and primary-care settings where they are often absent, supports core aspects of quality, equity and dignity for all people. This document describes an approach for conducting a nation...
The document is structured into five sections. The first presents the key experiences and challenges that justify a renewal of the EPHFs. The second section updates the groundwork for the exercise of public health and provides a framework to inform the exercise of the new essential functions. The th...
10 May 2021. Manufactureres:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
The ChAdOx1-S/nCoV-19 [recombinant] vaccine is a replication-deficient adenoviral vecto...
Nat Med (2021). https://doi.org/10.1038/s41591-021-01381-y
Background paper 8
The Independent Panel for Pandemic Preparedness and Response
May 2021
Background paper 10
The Independent Panel for Pandemic Preparedness and Response
May 2021
In the context of the coronavirus disease (COVID-19) pandemic response, WHO identifies young people as a priority target audience with specific concerns, experiences and behaviours. This policy brief provides relevant insights from behavioural evidence and a set of behavioural considerations for tho...
The WHO Guidance on community mental health services: Promoting person-centred and rights-based approaches document is part of the WHO Guidance and technical packages on community mental health services set of publications. It provides a detailed description of person-centred and human rights-based ...
3 June 2021. After 40 years of AIDS, charting a course to end the pandemic.
The report shows that countries with progressive laws and policies and strong and inclusive health systems have had the best outcomes against HIV. In those countries, people living with and affected by HIV are more likely t...
2nd edition, June 2021
In 2019, an estimated 10 million individuals fell ill with tuberculosis (TB) and 3 million of them were not reported to have beendiagnosed and notified. The gap is proportionately even wider for drug-resistant TB. Of the estimated 465 000 patients with rifampicin-resistant and multi-drug resistant T...
Interim guidanceAnnex to: Policy considerations for implementing a risk-based approach to international travel in the context of COVID-19, 2 July 2021
Against this background of nearly 20 years of experience of research, development and
improvement in patient safety, the role of incident and adverse event reporting, as well as the
benefits that derive from it, is still a work in progress.This document has two main purposes:
• to provide an up...
Injection practices worldwide and especially in low- and middle-income countries (LMICs) include multiple, avoidable unsafe practices that ultimately lead to the large-scale transmission of bloodborne viruses among patients, health care providers and the community at large.
